| Literature DB >> 33616841 |
Josiane Budni1, Arleide Braga Brandão2, Sabrina da Silva2, Michelle Lima Garcez2, Francielle Mina2, Tatiani Bellettini-Santos2, Gabriel Casagrande Zabot2, Eduarda Behenck Medeiros2, Giselli Scaini2, Jade de Oliveira3, Emílio Luiz Streck2, João Quevedo4,5,6,7.
Abstract
D-galactose (D-gal) is a carbohydrate widely distributed in regular diets. However, D-gal administration in rodents is associated with behavioral and neurochemical alterations similar to features observed in aging. In this regard, this study aimed to investigate the effects of D-gal exposure, in different periods, in rats' brain regions' activities of creatine kinase (CK) and tricarboxylic acid (TCA) cycle enzymes. Male adult Wistar rats received D-gal (100 mg/kg, gavage) for 1, 2, 4, 6 or 8 weeks. CK and TCA enzymes' activities were evaluated in rats' prefrontal cortex and hippocampus. In general, the results showed an increase in citrate synthase (CS) and succinate dehydrogenase (SDH) activities in animals treated with D-gal compared to the control group in the prefrontal cortex and hippocampus. Also, in the fourth week, the malate dehydrogenase (MD) activity increased in the hippocampus of rats that received D-gal compared to control rats. In addition, we observed an increase in the CK activity in the prefrontal cortex and hippocampus in the first and eighth weeks of treatment in the D-gal group compared to the control group. D-gal administration orally administered modulated TCA cycle enzymes and CK activities in the prefrontal cortex and hippocampus, which were also observed in aging and neurodegenerative diseases. However, more studies using experimental models are necessary to understand better the impact and contribution of these brain metabolic abnormalities associated with D-gal consumption for aging.Entities:
Keywords: Aging; Creatine kinase; D-galactose; Metabolism; Mitochondrial dysfunction; Tricarboxylic acid cycle enzymes
Mesh:
Substances:
Year: 2021 PMID: 33616841 DOI: 10.1007/s11011-021-00682-y
Source DB: PubMed Journal: Metab Brain Dis ISSN: 0885-7490 Impact factor: 3.584